Toll free: 1-800-411-1222 TTY: 1-866-411-1010 Fax: 301-480-9793 Mail: Patient Recruitment—ICICLE Study, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892-2655
ICICLE is a research study testing the safety of interleukin 7 (IL-7) in patients with idiopathic CD4 lymphocytopenia (ICL). People with ICL are at risk for serious infections and autoimmune disorders. Right now there is no proven treatment for ICL. Volunteer participation in this study will help NIH researchers learn about the safety of IL-7 taken at different doses and its ability to boost immune response in people with ICL who are at risk for disease progression.
If you are interested in participating in the study, you will be asked to answer some questions and then come to NIH for a screening visit to make sure you are healthy and able to participate. If you decide to participate in the study, you will be asked to visit NIH 16 times in 48 weeks for dosing and checkups. During the study, you will get six doses of the study drug (rhIL-7). The study drug is given by inserting a needle under your skin.
The study is being conducted at the Warren Grant Magnuson Clinical Center (Building 10) at NIH in Bethesda, MD, which is accessible by car and public transportation. After you are accepted in the study, you may be reimbursed for your travel expenses.
You may be able to participate if the following apply to you:
You cannot participate if any of the following apply to you:
You have had systemic treatment or hospitalization for a serious illness within 56 days (eight weeks) of screening
Note: If you have completed therapy or have been on therapy for more than four weeks prior to screening, and the study doctor says that you can participate, you may be able to participate in the ICICLE study.
There is no charge to participate in this research study. All study-related medical care, including clinic visits and procedures, are free.
Yes, you will be compensated for your participation in the study. Transportation and other expenses may also be covered.
If you have questions or would like more information, contact Patient Recruitment at the NIH Clinical Center.
Toll free: 1-800-411-1222TTY: 1-866-411-1010Fax: 301-480-9793Mail: Patient Recruitment—ICICLE Study, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892-2655
To learn more about the ICICLE study (trial ID: NCT00839436), visit ClinicalTrials.gov.
back to top
Last Updated June 23, 2010